Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Ripple Biosciences — Funding, Investors & Profile — Capbase

← All companies

Compare History

Ripple Biosciences

Private

Won a federal SBIR/STTR research award from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: XEALUFCB6HH5

Founded: —Source: [GOV]
Headquarters: GROSSE POINTE PARK, MichiganSource: [GOV]
Headcount: 2Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Ripple Biosciences has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $306,872 in 2025. These are non-dilutive federal research grants, not equity financing. The company is based in GROSSE POINTE PARK, Michigan.

Funding rounds

1 rounds

STTR Phase I award (HHS)GrantSep 2025Source: [GOV]
$306.9K
—post-money

Investors

No investors recorded yet for Ripple Biosciences.

Add an investor

People

Leadership

JRICHARD PILSNERPrincipal investigatorSince 2025Source: [GOV]

Acquisitions

Ripple Biosciences has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Ripple Biosciences.

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.